Characteristics of the subjects
. | OAC treatment . | . | . | |
---|---|---|---|---|
. | No preoperative OAC . | Preoperative OAC . | P . | |
Subjects, no. | 35 | 10 | na | |
Age, y, mean ± SD | 70.1 ± 8.5 | 73.4 ± 5.3 | ns | |
Sex, no. male/no. female | 15/20 | 4/6 | ns | |
Diabetes mellitus, no. | 3 | 1 | ns | |
Aortic valve stenosis | ||||
Grade II, no. | 7 | 3 | ns | |
Grade III, no. | 28 | 7 | ns | |
Insufficiency, no. | 19 | 6 | ns | |
INR, no. | < 1.2 | 2.4 ± 0.4 | < .01 | |
Calcification score, % | 16 | 37 | < .02 |
. | OAC treatment . | . | . | |
---|---|---|---|---|
. | No preoperative OAC . | Preoperative OAC . | P . | |
Subjects, no. | 35 | 10 | na | |
Age, y, mean ± SD | 70.1 ± 8.5 | 73.4 ± 5.3 | ns | |
Sex, no. male/no. female | 15/20 | 4/6 | ns | |
Diabetes mellitus, no. | 3 | 1 | ns | |
Aortic valve stenosis | ||||
Grade II, no. | 7 | 3 | ns | |
Grade III, no. | 28 | 7 | ns | |
Insufficiency, no. | 19 | 6 | ns | |
INR, no. | < 1.2 | 2.4 ± 0.4 | < .01 | |
Calcification score, % | 16 | 37 | < .02 |
na indicates not applicable; ns, not significant.